Shanghai RAAS Blood Products Co., Ltd. (002252) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai RAAS Blood Products Co., Ltd.

Why is Shanghai RAAS Blood Products Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 24.05% and Operating profit at 12.65% over the last 5 years

With a fall in PBT of -20.11%, the company declared Very Negative results in Mar 26

The company has declared negative results for the last 6 consecutive quarters
NET PROFIT(HY) At CNY 443.85 MM has Grown at -51.84%
INTEREST(HY) At CNY 41.59 MM has Grown at 10,509.54%
OPERATING CASH FLOW(Y) Lowest at CNY -686.81 MM

Below par performance in long term as well as near term

Along with generating -22.14% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai RAAS Blood Products Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai RAAS Blood Products Co., Ltd.

-100.0%

-2.08

13.69%

China Shanghai Composite

20.96%

1.57

13.38%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.05%

EBIT Growth (5y)

12.65%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.24

Tax Ratio

18.73%

Dividend Payout Ratio

20.14%

Pledged Shares

Institutional Holding

ROCE (avg)

7.22%

ROE (avg)

6.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.27

EV to EBIT

23.54

EV to EBITDA

21.68

EV to Capital Employed

1.26

EV to Sales

5.31

PEG Ratio

Dividend Yield

0.79%

ROCE (Latest)

5.36%

ROE (Latest)

5.60%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 1.64% (YoY

-37What is not working for the Company

NET PROFIT(HY)

At CNY 443.85 MM has Grown at -51.84%

INTEREST(HY)

At CNY 41.59 MM has Grown at 10,509.54%

OPERATING CASH FLOW(Y)

Lowest at CNY -686.81 MM

NET SALES(Q)

At CNY 1,509.49 MM has Fallen at -17.83%

ROCE(HY)

Lowest at 4.08%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.9 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.83 times

CASH AND EQV(HY)

Lowest at CNY 3,988.76 MM

DEBT-EQUITY RATIO (HY)

Highest at 6.37 %

Here's what is working for Shanghai RAAS Blood Products Co., Ltd.

Raw Material Cost

Fallen by 1.64% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai RAAS Blood Products Co., Ltd.

Net Profit

At CNY 443.85 MM has Grown at -51.84%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 41.59 MM has Grown at 10,509.54%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 1,509.49 MM has Fallen at -17.83%

over average net sales of the previous four periods of CNY 1,837.05 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY -686.81 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Lowest at 0.9 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.83 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Cash and Eqv

Lowest at CNY 3,988.76 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 6.37 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio